EODData

FRA, R5XA: ACELRX PHARMACEUT. DL-01

03 Nov 2026
LAST:

0.8850

CHANGE:
 0.03
OPEN:
0.8800
HIGH:
0.8850
ASK:
0.0000
VOLUME:
0
CHG(%):
3.28
PREV:
0.9150
LOW:
0.8800
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 260.88000.88500.88000.88500
02 Nov 260.90500.91500.90500.91500
30 Oct 260.93000.94500.93000.94500
29 Oct 260.95500.96500.95500.96500
28 Oct 260.96000.96000.95500.95500
27 Oct 260.93500.95000.93500.95000
23 Oct 260.91500.92500.91500.92500
22 Oct 260.92500.94500.92500.94500
21 Oct 260.93500.96000.93500.96000
20 Oct 260.94000.94000.93000.93000

PROFILE

Name:ACELRX PHARMACEUT. DL-01
About:Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Sector:Healthcare
Address:1850 Gateway Drive, San Mateo, CA, United States, 94404
Website:https://talphera.com
ISIN:US00444T2096

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:0.17 
PEG Ratio:0.00 
Price to Sales:49,050.98 
Price to Book:3.82 
Operating Margin:-14,747.00 
Return on Assets:-0.43 
Return on Equity:-1.43 
Revenue:895 
Shares:20.5M 
Market Cap:18.15M 

TECHNICAL INDICATORS

MA5:0.935.4%
MA10:0.945.9%
MA20:0.956.8%
MA50:0.9811.3%
MA100:0.9911.6%
MA200:0.863.3%
RSI14:38.89 
WPR14:-100.00 
MTM14:-0.06
ROC14:-0.06 
ATR:0.02 
Week High:0.979.0%
Week Low:0.880.6%
Month High:1.0114.1%
Month Low:0.883.3%
Year High:1.2541.2%
Year Low:0.6243.9%
Volatility:8.60 

RECENT SPLITS

Date Ratio
26 Oct 20221-20